Kary Eldred serves as Executive at GALECTIN THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Kary Eldred has executed 10 insider transactions totaling $39.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 23, 2025 involved purchasing 700 shares valued at $2.6K.
Kary Eldred currently holds 65,382 shares of GALECTIN THERAPEUTICS INC (GALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kary Eldred has been a net buyer of GALT stock. They have purchased $39.1K and sold $0 worth of shares.
Kary Eldred's most recent insider trade was on Dec 23, 2025, when they purchased 700 shares at $3.73 per share.
Get notified when new Form 4 filings are submitted
| $3.73 |
| Discretionary |
| Jul 22, 2024 | GALT | $956 | Purchase | 400 | $2.39 | Discretionary |
| Jan 16, 2024 | GALT | $956 | Purchase | 400 | $2.39 | Discretionary |
| Jan 16, 2024 | GALT | $895 | Purchase | 500 | $1.79 | Discretionary |
| Jul 19, 2023 | GALT | $2.9K | Purchase | 1,598 | $1.79 | Discretionary |
| Feb 21, 2023 | GALT | $1.6K | Purchase | 1,000 | $1.59 | Discretionary |
| Jan 25, 2023 | GALT | $1.4K | Purchase | 1,300 | $1.11 | Discretionary |
| May 31, 2019 | GALT | $13.0K | Purchase | 3,033 | $4.28 | Discretionary |
| Sep 25, 2018 | GALT | $12.2K | Purchase | 2,000 | $6.10 | Discretionary |